Equities Analysts Offer Predictions for APLS Q2 Earnings
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Equities research analysts at HC Wainwright reduced their Q2 2025 earnings per share (EPS) estimates for Apellis Pharmaceuticals in a report issued on Thursday, May 8th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per share of ($0.49) for the quarter, down […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Equities research analysts at HC Wainwright reduced their Q2 2025 earnings per share (EPS) estimates for Apellis Pharmaceuticals in a report issued on Thursday, May 8th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per share of ($0.49) for the quarter, down […]
